Baker, D. J., Wilkinson, G. P., Atkinson, A. M., Jones, H. B., Coghlan, M., Charles, A. D., & Leighton, B. (2014). Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes. Blackwell Publishing Ltd.

Baker, D J., G P. Wilkinson, A M. Atkinson, H B. Jones, M. Coghlan, A D. Charles, et B. Leighton. Chronic Glucokinase Activator Treatment At Clinically Translatable Exposures Gives Durable Glucose Lowering in Two Animal Models of Type 2 Diabetes. Blackwell Publishing Ltd, 2014.

Baker, D J., et al. Chronic Glucokinase Activator Treatment At Clinically Translatable Exposures Gives Durable Glucose Lowering in Two Animal Models of Type 2 Diabetes. Blackwell Publishing Ltd, 2014.